Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 versus placebo in young children with recurrent wheezing
2024-511083-90-00Phase 2Completed
- Sponsor
- OM Pharma
- Start
- Oct 2024
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in wheeze comparing OM-85 with Placebo (2 arms). Primary endpoint: Rate of wheezing or asthma-like episodes during treatment. Started Oct 2024; status: completed.
02
Drugs
OM-85
03
Conditions
wheeze
Beyond the preview
Go deeper on 2024-511083-90-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511083-90-00.